Navigation Links
UNT Regents Approve New College of Pharmacy
Date:8/24/2011

FORT WORTH, Texas, Aug. 24, 2011 /PRNewswire-USNewswire/ -- The UNT System Board of Regents approved a UNT System College of Pharmacy, as authorized in the 82nd Texas legislative session. As part of the three-way partnership among UNT, the UNT Health Science Center and UNT Dallas, the College of Pharmacy students will earn a Doctor of Pharmacy (PharmD) degree and will attend the graduate portion of their classes on the UNT Health Science Center campus at Fort Worth along with professional practice experience.  Additional classes may eventually expand to UNT and UNT Dallas.

The initial class of 80 students will begin in 2013, with classes expanding to 100 students by 2015. Entering students must have completed a pre-pharmacy curriculum prior to admission to the four-year doctoral program. The new college will follow prescribed steps to earn accreditation through the Accreditation Council for Pharmacy Education (ACPE).

Administrative leadership of the program will be through the Health Science Center, with acceptance and curriculum committees composed of representatives of all three UNT campuses. Glenn Dillon, Ph.D., vice president for research and professor of Pharmacology and Neuroscience at the Health Science Center, was named interim dean of the college reporting to Provost Thomas Yorio, Ph.D. Initial funding will be provided by UNTHSC and private donations.

This is the first college of pharmacy in the North Texas area.

UNT Health Science Center

The UNT Health Science Center comprises the Texas College of Osteopathic Medicine, the Graduate School of Biomedical Sciences, the School of Public Health, and the School of Health Professions. Key research areas include aging and Alzheimer's disease, applied genetics and primary care.  This year, the Texas College of Osteopathic Medicine was named a top 50 medical school in primary care by U.S. News & World Report f
'/>"/>

SOURCE UNT Health Science Center
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Adcetris to Treat Two Types of Lymphoma
2. FDA Approves the First Specific Treatment for Scorpion Stings
3. Cardinal Health Board of Directors Approves Cash Dividend, Elects David P. King as Director
4. FDA Tentatively Approves Intellijects Lead Product, e-cue™
5. Unapproved Emergency Birth Control Medicine Possibly in U.S. Distribution May Be Ineffective and Unsafe
6. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
7. FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US
8. FDA Approves Vaccines for the 2011-2012 Influenza Season
9. Shire plc: Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
10. Lialda® (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
11. Cephalon Shareholders Approve Acquisition by Teva
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of targeted antiviral therapies, announced ... Annual ROTH Conference, to be held March 8-11, ... James Sapirstein , Chief Executive Officer, ... his live presentation and will be available to participate ...
(Date:3/5/2015)... Calif. , March 5, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, announced today that ... the nation,s top rehabilitation hospitals for spinal cord injury ... 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in ... spinal cord injury (SCI). The Phase ...
(Date:3/5/2015)... YORK and VANCOUVER, British Columbia ... (CSE: BUX FSE: 20B OTCQB: BMKDF) -- The ultimate ... an assay that is capable of detecting tumors before ... forty years, the development of such an assay has ... in academia and industry. Although many breakthrough diagnostics have ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4
... of Rosetta Genomics, microRNA-based,Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous ... Diagnostic Methods, A Test Based on the miRview(TM) Technology First Approved for ... ... Earlier This Year, Rosetta Genomics is Expecting to Launch ...
... from the,French Medicine Agency (AFSSAPS) the authorization to ... PL37, its lead compound for oral,treatment of neuropathic ... pain condition, with an estimated,prevalence in the world,s ... most,recent surveys, with many causes such as shingles, ...
Cached Medicine Technology:Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... in healthcare communications and education, announced today its ... (AMP), the nation’s only medical conference designed for ... ischemia and lower limb amputation due to vascular ... family of innovative, evidence-based publications and CME activities ...
(Date:3/5/2015)... Califia Farms , the fastest-growing natural ... coffee drinks category[1], today unveils its new Concentrated Cold ... Calif. Concentrated Cold Brew (CCB) is the centerpiece ... the next wave of the coffee-taste evolution by giving ... their own baristas. , Califia Farms CCB has ...
(Date:3/5/2015)... March 05, 2015 Taking center ... Fort Worth, Texas April 9-11th is IDRevolution hosted ... providing personalized nutrition. IDLife offers a variety ... This customized approach to vitamin supplementation is ... with a free HIPAA compliant online assessment and ...
(Date:3/5/2015)... San Diego, CA (PRWEB) March 05, 2015 ... only the purest and most essential ingredients, the robust ... risk of allergic reactions. PASCHA Chocolate is free ... rice and sesame. Experience PASCHA's offering March 6th- 8th ... Smile! Chocolate Spread. PASCHA Chocolate has broken new ...
(Date:3/5/2015)... 2015 INTEGRATED Healthcare Strategies, a ... participate in its 2015 Children’s Hospitals Executive Compensation ... director-level positions, and the survey results are exclusive ... featured data on 60 executive and director level ... and 7 subsidiary children’s hospitals. Additionally, it provided ...
Breaking Medicine News(10 mins):Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2
... commentary on the concerns of successive Australian governments, a ... the health of aborigines lags an appalling one century ... Torres Strait Islander people have significantly worse outcomes than ... ,In New Zealand, while inequality exists between Maori ...
... to improve patient care. In a recent report the use of ... US alone who succumb to sudden infant death syndrome each year. ... of Texas has come up with a new solution for sudden ... along with his friends developed a device that can warn a ...
... is causing confusion among scientists, //is the mystery of ... decipher the reason for this. Normal healthy adult bees abandon the ... ago it was seen that a mass exodus would leave the ... in the new phenomenon it is seen that new bees ...
... height of their football career is unparallel. This glamour and ... retires, and very soon replaced with depression. This is highlighted ... Health System. ,The chronic pain of the injuries ... often come to fore once they retire. This coupled with ...
... that antioxidant supplements interfere with the therapeutic effects ... //review of the use of antioxidants during chemotherapy. ... tumor response, and the patient’s ability to tolerate ... whose oncologists discourage the use of antioxidant supplements ...
... unusual scourge among the Mauritanian nomads - the force-feeding of ... ideal for brides-to-be. ,Mothers cross sticks around the ... girls cry out in pain. ,That is one ... of couscous for days on end until they developed wings ...
Cached Medicine News:Health News:Aborigines Century Behind the Health of Colonizers, WHO Report 2Health News:RFID Use can Avoid Sudden Infant Death Syndrome 2Health News:Vanishing Honey Bees 2Health News:Ex Pro-football Players Saddled With Depression After Retirement 2Health News:Antioxidants May Aid Chemotherapy Patients 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 2Health News:Force-feeding a Scourge Among Mauritanian Nomads 3
The BacT/Alert 3D Select Link is a state of the art, automated microbial detection system that integrates blood, sterile body fluid and mycobacteria culturing. This system is useful when patient data...
The Vitek 2 - XL is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat ...
IDS Rapid Yeast Plus, a microbial identification system....
IDS Rapid One, a microbial identification system....
Medicine Products: